Cargando…
Impact of IL-23 in prostate cancer
Autor principal: | Mirlekar, Bhalchandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887111/ https://www.ncbi.nlm.nih.gov/pubmed/34850747 http://dx.doi.org/10.4103/aja2021100 |
Ejemplares similares
-
Tumor promoting roles of IL-10, TGF-β, IL-4, and IL-35: Its implications in cancer immunotherapy
por: Mirlekar, Bhalchandra
Publicado: (2022) -
IL-12 Family Cytokines in Cancer and Immunotherapy
por: Mirlekar, Bhalchandra, et al.
Publicado: (2021) -
Separate Chinese lines for prostate cancer?
por: von Eyben, Finn Edler
Publicado: (2019) -
Optimal treatment for castration-resistant prostate cancer
por: Izumi, Kouji, et al.
Publicado: (2014) -
Serum lipid profiles and aggressive prostate cancer
por: Li, Yanjing, et al.
Publicado: (2015)